Publicaciones (61) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. AB1352 Impact of Systemic Therapies on the Seroprevalence of Sars-Cov-2 in Patients with Immune-Mediated Diseases

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1907.1-1907

  2. AB1470 Janus Kinase Inhibitors in Severe Inflammatory Ocular Pathology. Multicenter Study and Literature Review

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1963.2-1964

  3. Anxiety and depression in patients with narcolepsy

    Journal of Sleep Research, Vol. 32, Núm. 4

  4. Biological sequential therapy with rituximab-belimumab in patients with recurrent lupus nephritis

    Reumatologia Clinica

  5. Blood analysis for screening of electrolyte and kidney function alterations in patients with febrile urinary tract infection

    Acta Paediatrica, International Journal of Paediatrics, Vol. 112, Núm. 10, pp. 2202-2209

  6. Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy

    Frontiers in Immunology, Vol. 14

  7. Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change

    Journal of Acquired Immune Deficiency Syndromes, Vol. 93, Núm. 1, pp. 42-46

  8. Clinical Characteristics and Prognostic Impact of Short Physical Performance Battery in Hospitalized Patients with Acute Heart Failure—Results of the PROFUND-IC Registry †

    Journal of Clinical Medicine, Vol. 12, Núm. 18

  9. Clinical features and lipid metabolism genes as potential biomarkers in advanced lung cancer

    BMC Cancer, Vol. 23, Núm. 1

  10. Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

    Cancer Medicine, Vol. 12, Núm. 14, pp. 14892-14901

  11. Clinical practice selectively follows acute appendicitis guidelines

    European Journal of Trauma and Emergency Surgery, Vol. 49, Núm. 1, pp. 45-56

  12. Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review

    Current Oncology, Vol. 30, Núm. 10, pp. 9335-9345

  13. Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)

    Ophthalmology and Therapy

  14. Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study

    Translational Lung Cancer Research, Vol. 12, Núm. 2, pp. 247-256

  15. Donor lungs cold preservation at 10 °C offers a potential logistic advantage in lung transplantation

    Cirugia Espanola, Vol. 101, Núm. 4, pp. 283-286

  16. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 307-317

  17. Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile

    Pediatric Research, Vol. 94, Núm. 5, pp. 1667-1674

  18. Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

    Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 6, pp. 1423-1432

  19. Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study

    Neurologia, Vol. 38, Núm. 6, pp. 379-386

  20. Evolocumab como tratamiento de la dislipemia secundaria a lorlatinib

    Clínica e investigación en arteriosclerosis, Vol. 35, Núm. 2, pp. 88-90